Plain-English translation of NCT06425926 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 1/2 โ A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This is an early-stage trial testing a new medication called for people with advanced cancers that have spread or stopped responding to standard treatments. Researchers want to understand how safe this medication is, how your body processes it, and whether it can slow or stop cancer growth. In the first part of the study, participants take the medication alone; in the second part, some people take it alongside an immunotherapy drug called an anti-PD-1 therapy.
Many people with advanced solid tumors run out of effective treatment options, especially melanoma patients whose cancer has stopped responding to immunotherapy. This trial exists to find out whether this new medication could offer hope to those patients by working differently than current treatments or working better when combined with existing therapies.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You would take this medication by mouth once daily at home. You would attend regular clinic visits for blood tests, heart rhythm monitoring, and imaging scans to track how your cancer responds and to watch for side effects. Depending on which part of the trial you join (Phase 1 or Phase 2), you might be in the study for several months to over a year, and the study team will follow your health closely throughout.
AI-generated summary from trial data ยท Aug 24, 2026 ยท Not medical advice
United States